Authors: Cogoi, S Suraci, C Del Terra, E Diviacco, S Van der Marel, G Van Boom, J Quadrifoglio, F Xodo, L

Citation: S. Cogoi et al., Downregulation of c-Ki-ras promoter activity by triplex-forming oligonucleotides endogenously generated in human 293 cells, ANTISENSE N, 10(4), 2000, pp. 283-295

Authors: Pozzilli, P Pitocco, D Visalli, N Cavallo, MG Buzzetti, R Crino, A Spera, S Suraci, C Multari, G Cervoni, M Bitti, MLM Matteoli, MC Marietti, G Ferrazzoli, F Faldetta, MRC Giordano, C Sbriglia, M Sarugeri, E Ghirlanda, G

Citation: P. Pozzilli et al., No effect of oral insulin on residual beta-cell function in resent-onset Type I diabetes (the IMDIAB VII), DIABETOLOG, 43(8), 2000, pp. 1000-1004

Authors: Visalli, N Cavallo, MG Signore, A Baroni, MG Buzzetti, R Fioriti, E Mesturino, C Fiori, R Lucentini, L Matteoli, MC Crino, A Corbi, S Spera, S Teodonio, C Paci, F Amoretti, R Pisano, L Suraci, C Multari, G Sulli, N Cervoni, M De Mattia, G Faldetta, MRC Boscherini, B Bitti, MLM Marietti, G Ferrazzoli, F Bizzarri, C Pitocco, D Ghirlanda, G Pozzilli, P

Citation: N. Visalli et al., A multi-centre randomized trial of two different doses of nicotinamide in patients with recent-onset type 1 diabetes (the IMDIAB VI), DIABET M R, 15(3), 1999, pp. 181-185

Authors: Parlapiano, C Marangi, M Campana, E Giovanniello, T Pantone, P Suraci, C Sanguigni, S

Citation: C. Parlapiano et al., Anti-neutrophil cell antibodies in newly diagnosed patients with type-1-diabetes, EXP CL E D, 107(5), 1999, pp. 328-329